Opendata, web and dolomites

SAFE-CAB SIGNED

Laser-Assisted Surgical System to Revolutionize Cardiac Bypass Surgeries

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SAFE-CAB project word cloud

Explore the words cloud of the SAFE-CAB project. It provides you a very rough idea of what is the project "SAFE-CAB" about.

artery    final    arresting    sme    replace    700    reduce    training       cardiac    regulatory    clinical    arrested    disease    suturing    shorter    amt    extremely    professional    hospital    severe    berlin    192m    opportunity    society    chest    market    solutions    safe    kit    laser    infarction    readiness    invasive    vision    pan    oldest    assisted    recovery    translates    treat    first    heart    health    annually    surgical    entry    15    cardiovascular    bypass    myocardial    procedure    seeking    replacing    herzzentrum    patient    accelerate    survival    outcomes    company    substantially    endovascular    catheter    deutsches    blood    obtain    containing    annual    validation    surgery    hemex    medical    group    closed    thereby    flow    89m    approval    coronary    device    complemented    organisation    implant    lt    standard    lifetec    times    complications    dutch    performed    patients    technically    minimally    cab    attack    surgeons    gt    rates    proprietary    risk    beating    prevent    care    realize    surgeries   

Project "SAFE-CAB" data sheet

The following table provides information about the project.

Coordinator
AMT MEDICAL RESEARCH BV 

Organization address
address: YALELAAN 52
city: UTRECHT
postcode: 3584 CM
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 2˙850˙312 €
 EC max contribution 2˙182˙118 € (77%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2022-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AMT MEDICAL RESEARCH BV NL (UTRECHT) coordinator 397˙250.00
2    HEMEX AG CH (LIESTAL) participant 903˙875.00
3    DEUTSCHES HERZZENTRUM BERLIN DE (BERLIN) participant 432˙625.00
4    LIFETEC GROUP BV NL (EINDHOVEN) participant 257˙993.00
5    EUROPEAN SOCIETY FOR CARDIOVASCULAR AND ENDOVASCULAR SURGERY CH (ZURICH) participant 190˙375.00

Map

 Project objective

Coronary Artery Bypass (CAB) surgery is performed annually in >700,000 patients to treat coronary artery disease and prevent myocardial infarction (heart attack). Standard CAB surgery involves a highly invasive open-heart procedure in arrested/non-beating heart, that is associated with long recovery times and severe complications. The surgeons are seeking for less invasive, closed chest CAB procedures on beating heart, but current solutions are technically extremely challenging and thereby only used in <1-3% of all surgeries. The vision of the SAFE-CAB consortium is to make the minimally invasive CAB surgeries available to all surgeons as a novel standard of care, thereby substantially improve patient outcomes and reduce health care costs. The goal of the project is to bring to market a first-of-its-kind laser-assisted minimally invasive surgical system (surgical kit containing surgical implant and laser catheter). SAFE-CAB enables minimally invasive procedure on beating heart, without the need for arresting blood flow or complex hand suturing. With shorter recovery times, less complications and improved survival rates in high-risk patients, the SAFE-CAB technology has a potential to replace high-risk open-heart surgeries. Replacing only 15% of open-heart surgeries in Europe and US translates to annual market opportunity of >€89M and >€192M. Dutch SME AMT Medical has developed the proprietary SAFE-CAB technology to clinical readiness. To substantially accelerate the market entry of the product, the company partners with a leading European cardiac surgery hospital Deutsches Herzzentrum Berlin and a pan-European clinical/regulatory medical device company HEMEX to obtain regulatory approval through final clinical validation . To realize European wide-implementation, the consortium is complemented by a surgery training company LifeTec Group and the oldest professional organisation for cardiac surgeons European Society of CardioVascular and Endovascular Surgery.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAFE-CAB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAFE-CAB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

Bio-LP-1 (2020)

A novel rapid environmental test for the human pathogen Legionella

Read More  

PAV-DT (2019)

A disruptive technology that enables low cost real-time monitoring of road pavement condition by any ordinary vehicle circulating on the road, and automatically designs plans for predictive maintenance.

Read More  

SAMBAfun (2018)

System for AcceleroMeter-Based Assessment of cardiac FUNction

Read More